Related Experiment Video
Updated: Sep 16, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
"Unraveling EMILIN-1: A Multifunctional ECM Protein with Tumor-Suppressive Roles" Mechanistic Insights into Cancer
Samanta Muzzin1, Enrica Timis1, Roberto Doliana1
1Molecular Oncology Unit, Centro di Riferimento Oncologico Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 33081 Aviano, Italy.
Elastin Microfibril Interface Located Protein 1 (EMILIN-1) exhibits tumor-suppressive functions by regulating cell proliferation and the tumor microenvironment. Reduced EMILIN-1 expression correlates with cancer progression, highlighting its therapeutic potential.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- EMILIN-1 is an extracellular matrix glycoprotein with structural and regulatory roles.
- Initially known for elastogenesis and vascular homeostasis, EMILIN-1 is now recognized for tumor-suppressive functions.
Purpose of the Study:
- To review the current knowledge on EMILIN-1 in cancer biology.
- To focus on EMILIN-1's mechanisms in controlling cell proliferation and its potential as a biomarker and therapeutic target.
Main Methods:
- Literature review summarizing current research on EMILIN-1 in cancer.
- Analysis of EMILIN-1's molecular interactions and signaling pathways (e.g., ERK/AKT, TGF-β, integrins).
Main Results:
- EMILIN-1 inhibits tumor cell proliferation and survival through direct and indirect mechanisms.
- EMILIN-1 modulates lymphangiogenesis and the tumor inflammatory microenvironment.
- Reduced EMILIN-1 expression or altered structure is linked to advanced cancers and poor prognosis.
Conclusions:
- EMILIN-1 acts as an extracellular matrix regulator of intercellular signaling with significant anti-tumor activity.
- EMILIN-1's role in controlling cell proliferation and its frequent downregulation in cancer suggest its potential as a biomarker and therapeutic target.
More Related Videos
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
12:14CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
Published on: June 2, 2022
Related Concept Videos
Mitogens and the Cell Cycle
The Tumor Microenvironment
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...